Griffin Stephen D. bought ANIK
June 3, 2024 · Form 4 insider transaction
Griffin Stephen D. bought 96,525 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
96,525
Price
$0.00
Total value
N/A
InsiderGriffin Stephen D.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 3, 2024
Filing dateJune 5, 2024
Shares owned after96,525
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a 10% premium above the closing price of Anika's common stock on the date of grant.; The premium priced stock options vest in three equal annual installments beginning on June 3, 2025.